These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 29944701)

  • 21. Evaluation of the Xpert MTB/RIF assay for diagnosis of tuberculosis and rifampin resistance in county-level laboratories in Hunan province, China.
    Hu P; Bai L; Liu F; Ou X; Zhang Z; Yi S; Chen Z; Gong D; Liu B; Guo J; Tan Y
    Chin Med J (Engl); 2014; 127(21):3744-50. PubMed ID: 25382330
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Yield and Efficiency of Novel Intensified Tuberculosis Case-Finding Algorithms for People Living with HIV.
    Yoon C; Semitala FC; Asege L; Katende J; Mwebe S; Andama AO; Atuhumuza E; Nakaye M; Armstrong DT; Dowdy DW; McCulloch CE; Kamya M; Cattamanchi A
    Am J Respir Crit Care Med; 2019 Mar; 199(5):643-650. PubMed ID: 30192649
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Accuracy of Determine TB-LAM Ag to detect TB in HIV infected patients associated with diagnostic methods used in Brazilian public health units.
    Benjamin A; Cavalcante SC; Jamal LF; Arakaki-Sanchez D; de Lima JN; Pilotto JH; de Oliveira Junior FI; Souza TNL; Lourenço MC; de Mello MB; do Brasil PEAA; Barreira D; Rolla V
    PLoS One; 2019; 14(9):e0221038. PubMed ID: 31550246
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tuberculosis Case Finding in HIV-Infected Pregnant Women in Kenya Reveals Poor Performance of Symptom Screening and Rapid Diagnostic Tests.
    LaCourse SM; Cranmer LM; Matemo D; Kinuthia J; Richardson BA; John-Stewart G; Horne DJ
    J Acquir Immune Defic Syndr; 2016 Feb; 71(2):219-27. PubMed ID: 26334736
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of the Xpert MTB/RIF assay at a tertiary care referral hospital in a setting where tuberculosis and HIV infection are highly endemic.
    O'Grady J; Bates M; Chilukutu L; Mzyece J; Cheelo B; Chilufya M; Mukonda L; Mumba M; Tembo J; Chomba M; Kapata N; Maeurer M; Rachow A; Clowes P; Hoelscher M; Mwaba P; Zumla A
    Clin Infect Dis; 2012 Nov; 55(9):1171-8. PubMed ID: 22806590
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Outcomes of a clinical diagnostic algorithm for management of ambulatory smear and Xpert MTB/Rif negative HIV infected patients with presumptive pulmonary TB in Uganda: a prospective study.
    Walusimbi S; Semitala F; Bwanga F; Haile M; De Costa A; Davis L; Joloba M; Hoffner S; Kamya M
    Pan Afr Med J; 2016; 23():154. PubMed ID: 27303572
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Implementation Research to Inform the Use of Xpert MTB/RIF in Primary Health Care Facilities in High TB and HIV Settings in Resource Constrained Settings.
    Muyoyeta M; Moyo M; Kasese N; Ndhlovu M; Milimo D; Mwanza W; Kapata N; Schaap A; Godfrey Faussett P; Ayles H
    PLoS One; 2015; 10(6):e0126376. PubMed ID: 26030301
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Burden of tuberculosis in intensive care units in Cape Town, South Africa, and assessment of the accuracy and effect on patient outcomes of the Xpert MTB/RIF test on tracheal aspirate samples for diagnosis of pulmonary tuberculosis: a prospective burden of disease study with a nested randomised controlled trial.
    Calligaro GL; Theron G; Khalfey H; Peter J; Meldau R; Matinyenya B; Davids M; Smith L; Pooran A; Lesosky M; Esmail A; Miller MG; Piercy J; Michell L; Dawson R; Raine RI; Joubert I; Dheda K
    Lancet Respir Med; 2015 Aug; 3(8):621-30. PubMed ID: 26208996
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reassessment of the positive predictive value and specificity of Xpert MTB/RIF: a diagnostic accuracy study in the context of community-wide screening for tuberculosis.
    Ho J; Nguyen PTB; Nguyen TA; Tran KH; Van Nguyen S; Nguyen NV; Nguyen HB; Luu KB; Fox GJ; Marks GB
    Lancet Infect Dis; 2016 Sep; 16(9):1045-1051. PubMed ID: 27289387
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tuberculosis case finding using population-based disease surveillance platforms in urban and rural Kenya.
    Bigogo G; Cain K; Nyole D; Masyongo G; Auko JA; Wamola N; Okumu A; Agaya J; Montgomery J; Borgdorff M; Burton D
    BMC Infect Dis; 2018 Jun; 18(1):262. PubMed ID: 29879917
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mortality in the first six months among HIV-positive and HIV-negative patients empirically treated for tuberculosis.
    Huerga H; Ferlazzo G; Wanjala S; Bastard M; Bevilacqua P; Ardizzoni E; Sitienei J; Bonnet M
    BMC Infect Dis; 2019 Feb; 19(1):132. PubMed ID: 30744603
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Test and Treat TB: a pilot trial of GeneXpert MTB/RIF screening on a mobile HIV testing unit in South Africa.
    Bassett IV; Forman LS; Govere S; Thulare H; Frank SC; Mhlongo B; Losina E
    BMC Infect Dis; 2019 Feb; 19(1):110. PubMed ID: 30717693
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Performance of Clinical Screening Algorithms for Tuberculosis Intensified Case Finding among People Living with HIV in Western Kenya.
    Modi S; Cavanaugh JS; Shiraishi RW; Alexander HL; McCarthy KD; Burmen B; Muttai H; Heilig CM; Nakashima AK; Cain KP
    PLoS One; 2016; 11(12):e0167685. PubMed ID: 27936146
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Incremental Yield of Including Determine-TB LAM Assay in Diagnostic Algorithms for Hospitalized and Ambulatory HIV-Positive Patients in Kenya.
    Huerga H; Ferlazzo G; Bevilacqua P; Kirubi B; Ardizzoni E; Wanjala S; Sitienei J; Bonnet M
    PLoS One; 2017; 12(1):e0170976. PubMed ID: 28125693
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Incremental yield and cost of urine Determine TB-LAM and sputum induction in seriously ill adults with HIV.
    Boyles TH; Griesel R; Stewart A; Mendelson M; Maartens G
    Int J Infect Dis; 2018 Oct; 75():67-73. PubMed ID: 30125689
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of the Xpert MTB/RIF assay for the diagnosis of smear-negative pulmonary and extrapulmonary tuberculosis in Madagascar.
    Rakotoarivelo R; Ambrosioni J; Rasolofo V; Raberahona M; Rakotosamimanana N; Andrianasolo R; Ramanampamonjy R; Tiaray M; Razafimahefa J; Rakotoson J; Randria M; Bonnet F; Calmy A;
    Int J Infect Dis; 2018 Apr; 69():20-25. PubMed ID: 29408360
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Microbiologically Confirmed Tuberculosis: Factors Associated with Pre-Treatment Loss to Follow-Up, and Time to Treatment Initiation.
    Mwansa-Kambafwile J; Maitshotlo B; Black A
    PLoS One; 2017; 12(1):e0168659. PubMed ID: 28068347
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Rapid diagnosis of pulmonary tuberculosis in African children in a primary care setting by use of Xpert MTB/RIF on respiratory specimens: a prospective study.
    Zar HJ; Workman L; Isaacs W; Dheda K; Zemanay W; Nicol MP
    Lancet Glob Health; 2013 Aug; 1(2):e97-e104. PubMed ID: 25104164
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Development of a standardized screening rule for tuberculosis in people living with HIV in resource-constrained settings: individual participant data meta-analysis of observational studies.
    Getahun H; Kittikraisak W; Heilig CM; Corbett EL; Ayles H; Cain KP; Grant AD; Churchyard GJ; Kimerling M; Shah S; Lawn SD; Wood R; Maartens G; Granich R; Date AA; Varma JK
    PLoS Med; 2011 Jan; 8(1):e1000391. PubMed ID: 21267059
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Performance of the Xpert MTB/RIF assay in the diagnosis of tuberculosis in formalin-fixed, paraffin-embedded tissues.
    Polepole P; Kabwe M; Kasonde M; Tembo J; Shibemba A; O'Grady J; Kapata N; Zumla A; Bates M
    Int J Mycobacteriol; 2017; 6(1):87-93. PubMed ID: 28317811
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.